An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura
- 14 June 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 11 (8), 1511-1518
- https://doi.org/10.1111/jth.12319
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 HL72917, R01 HL89746, U54 HL112303)
This publication has 35 references indexed in Scilit:
- Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpuraHaematologica, 2011
- ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcomeHaematologica, 2011
- Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathiesThrombosis and Haemostasis, 2011
- Multi‐step binding of ADAMTS‐13 to von Willebrand factorJournal of Thrombosis and Haemostasis, 2009
- Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage siteBlood, 2009
- Mechanistic Studies on ADAMTS13 CatalysisBiophysical Journal, 2008
- Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)Journal of Thrombosis and Haemostasis, 2008
- Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobinBlood, 2005
- Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpuraBlood, 2004
- Escherichia coli maltose‐binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fusedProtein Science, 1999